Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: A theory

Journal of Theoretical Biology

Volumn 181, Issue 3, 1996, Pages 273-291

  Zhu, Bao Ting ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR; PARTIAL AGONIST; RECEPTOR BLOCKING AGENT;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR OCCUPANCY;

EID: 0030573674     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1996.0130     Document Type: Article

References (46)

1. ARIËNS, E. J. (1954). Affinity and intrinsic activity in the theory of competitive inhibition. Arch. Int. Pharmacodynamie Therapie 99, 32-49.
2. ARIËNS, E. J. & DE GROOT, W. M. (1954). Affinity and intrinsic-activity in the theory of competitive inhibition. Part III. Homologous decamethonium-derivatives and succinyl-cholineesters. Arch. Intern. Pharmacodynamie Therapie 99, 193-205.
3. ARIËNS, E. J., SIMONIS, A. M. & DE GROOT, W. M. (1955). Affinity and intrinsic-activity in the theory of competitive-and noncompetitive inhibition and analysis of some forms of dualism in action. Arch. Int. Pharmacodynamie Therapie 100, 298-322.
4. x values in the analysis of pharmacodynamics. Arch. Int. Pharmacodynamie Therapie 110, 275-299.
5. ARIËNS, E. J., VAN ROSSUM, J. M. & SIMONIS, A. M. (1956a). A theoretical basis of molecular pharmacology. Part II: Interactions of one or two compounds with two interdependent receptor systems. Arzneimittel-Forsch. 6, 611-621.
6. ARIËNS, E. J., VAN ROSSUM, J. M. & SIMONIS, A. M. (1956b). A theoretical basis of molecular pharmacology, part III. Arzneimittel-Forsch. 6, 737-746.
7. ARIËNS, E. J., SIMONIS, A. M. & VAN ROSSUM, J. M. (1964a). Drug-receptor interaction: Interaction of one or more drugs with one receptor system. In: Molecular Pharmacology, Vol. I (Ariëns, E. J., ed), pp. 119-286. New York: Academic Press.
8. ARIËNS, E. J., SIMONIS, A. M. & VAN ROSSUM, J. M. (1964b). Drug-receptor interaction: Interaction of one or more drugs with different receptor systems, in Molecular Pharmacology, Vol. I (Ariëns, E. J., ed), pp. 287-393. New York: Academic Press.
9. ARIËNS, E. J. (1966). Receptor theory and structure activity relationships. In: Advances in Drug Research (Harper N. J. & Simmonds, A. B., eds) pp. 235-285. London: Academic Press.
10. 1B receptor expression system. Mol. Pharmacol. 43, 427-433.
11. BLACK, J. W. & LEFF, P. (1983). Operational models of pharmacological agonism. Proc. R. Soc. Lond. B 220, 141-162.
12. BOURNE, H. R. & ROBERTS, J. M. (1995). Drug receptors and pharmacodynamics. In: Basic and Clinical Pharmacology - Sixth edition (Katzung, B. G., ed) pp. 9-32. Norwalk, CN: Appleton & Lange.
13. COLQUHOUN, D. (1972). The relation between classical and cooperative models for drug action, in Drug Receptors (Rang H. P., ed) pp. 149-182. London: Academic Press.
14. 2 receptor agonists in the treatment of Schizophrenia. Psychopharmacol. Bull. 25, 393-397.
15. FACKLAM, M., SCHOCH, P., BONETTI, E. P., JENCK, F., MARTIN, J. R., MOREAU, J-L. & HAEFELY, W. E. (1992). Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 261, 1113-1121.
16. FURCHGOTT, R. F. (1966). The use of α-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 3, 21-55.
17. FURCHGOTT, R. F. & BURSZTYN, P. (1967). Comparison of dissociation constants and relative efficacies of selected agonists acting on parasympathetic receptors. Ann. N. Y. Acad. Sci. 144, 882-898.
18. FURLONG, R. & BROGDEN, R. N. (1988). Xamoterol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs 36, 455-474.
19. HAEFELY, W., MARTIN, J. R. & SCHOCH, P. (1990). Novel anxiolytics that act as partial agonists at benzodiazepine receptors. TiPS 11, 452-456.
20. HOTTORI, Y., SAKUMA, I., NAKAO, Y. & KANNO, M. (1987). Pharmacological analysis of the cardiac actions of Xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in Guinea pig heart: Evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. J. Pharmacol. Exp. Ther. 242, 1077-1085.
21. IKÄHEIMO, M. J. & TAKKUNEN, J. T. (1984). The effects of beta1-adrenoceptor partial agonist ICI 118,587 on left ventricular function in patients with coronary heart disease. Int. J. Cardiol. 5, 339-351.
22. JENNINGS, G., BOBIK, A., ODDIE, C. & RESTALL, R. (1984). Cardioselective, kinetics, hemodynamics, and metabolic effects of xamoterol. Clin. Pharmacol. Ther. 35, 594-603.
23. KENAKIN T. P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 36, 165-222.
24. KENAKIN T. P. (1985). The quantification of relative efficacy of agonists. J. Pharmacol. Methods 13, 281-308.
25. ++ transients. J. Pharmacol. Exp. Ther. 265, 1292-1300.
26. KRAUPP, O., STUMPF, C., HERZFELD, E. & PILLAT, U. B. (1955). Pharmakologische eigenschaften einiger langwirksamer cholinesterase-hemmkörper aus der reihe der polymethylen-bis-carbaminoyl-m-trimethylammoniumphenole. Arch. Int. Pharmacodynamie Therapie 102, 281-303.
27. 1-adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction. Br. Heart J. 54, 17-21.
28. 1-adrenoceptor partial agonist. Br. J. Pharmacol. 77, 381-388.
29. PATIL, P. N., LAPIDUS, J. B. & TYE, A. (1967). Steric aspects of adrenergic drugs. II. Effects of dl-isomers and desoxy derivatives on the reserpine-pretreated vas deferens. J. Pharmacol. Exp. Ther. 115, 1-12.
30. PORTOGHESE, P. S., RONSISVALLE, G., LARSON, D. L., YIM, C. B., SAYRE, L. M. & TAKEMORI, A. E. (1982). Opioid agonist and antagonist bivalent ligands as receptor probes. Life Sci. 31, 1280-1286.
31. PORTUGESE, P. S., LARSON, D. L., YIM, C. B., SAYRE, L. M., RONSISVALLE, G., LIPKOWSKI, A. W., ET AL. (1985). Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. J. Med. Chem. 28, 1140-1141.
32. 1 adrenoceptor partial agonist, ICI 118,587. Eur. Heart J. 3 (suppl. D), 123-127.
33. 1 partial agonist (Corwin) on left ventricular function and myocardial infarction. Am. J. Cardiol. 51, 1267-1274.
34. ROTH, J. & GRUNFELD, C. (1981). Endocrine systems: mechanisms of disease, target cells, and receptors. In: Textbook of Endocrinology, sixth edition (Williams R. H., ed), Philadelphia: W. B. Saunders Co.
35. RUFFOLO, R. R., ROSING, E. L. & WADDEL, J. E. (1979). Receptor interactions of imidazolines. I. Affinity and efficacy for α-adrenergic receptors in rat aorta. J. Pharmacol. Exp. Ther. 209, 429-436.
36. RUFFOLO, R. R., WADDELL, J. E. & YADEN, E. L. (1980). Receptor interactions of imidazolines. IV. Structural requirements for alpha adrenergic receptor occupation and receptor activation by clonidine and a series of structural analogs in rat aorta. J. Pharmacol. Exp. Ther. 213, 267-272.
37. RUFFOLO, R. R. & WADDELL, J. E. (1982). Receptor interactions of imidazolines: α-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. Br. J. Pharmacol. 77, 169-176.
38. 1-adrenoceptor partial agonist treatment for congestive heart failure. Cardiology 77, 357-366.
39. SHIMOHIGASHI, Y., COSTA, T., MATSUURA, S., CHEN, H.-C. & RODBARD, D. (1982). Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor. Mol. Pharmacol. 21, 558-563.
40. STEPHENSON, R. P. (1956). A modification of receptor theory. Br. J. Pharmacol. 11, 379-393.
41. SZABADI, E. (1977). A model of two functionally antagonistic receptor populations achieved by the same agonist. J. theor. Biol. 69, 101-112.
42. TAYLOR, P. & INSEL, P. A. (1990). Molecular basis of pharmacologic selectivity. In: Principles of Drug Actions - The Basis of Pharmacology, Third edition (Pratt W. B. & Taylor P., eds) pp. 1-102. New York: Churchill Livingstone.
43. THRON, C. D. (1973). On the analysis of pharmacological experiments in term of an allosteric receptor model. Mol. Pharmacol. 9, 1-9.
44. VAN ROSSUM, J. M. & ARIËNS, E. J. (1959a). Pharmacodynamics of drugs affecting skeletal muscle. Structure-action relationships in homologous series of quaternary ammonium salts. Arch. Int. Pharmacodynamie Therapie 118, 393-417.
45. VAN ROSSUM, J. M. & ARIËNS, E. J. (1959b). Pharmacodynamics of parasympathetic drugs. Structure-action relationships in homologous series of quaternary ammonium salts. Arch. Int. Pharmacodynamie Therapie 118, 418-446.
46. ZHU, B. T. (1993). The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors. J. Pharmacol. Toxicol. Methods 29, 85-91.